- Home
- WDFC vs SRRK Comparison
WDFC vs SRRK Comparison
Compare WDFC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDFC
- SRRK
- Stock Information
- Founded
- WDFC 1953
- SRRK 2012
- Country
- WDFC United States
- SRRK United States
- Employees
- WDFC N/A
- SRRK N/A
- Industry
- WDFC Major Chemicals
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WDFC Industrials
- SRRK Health Care
- Exchange
- WDFC Nasdaq
- SRRK Nasdaq
- Market Cap
- WDFC 3.1B
- SRRK 3.2B
- IPO Year
- WDFC N/A
- SRRK 2018
- Fundamental
- Price
- WDFC $217.23
- SRRK $40.72
- Analyst Decision
- WDFC Strong Buy
- SRRK Strong Buy
- Analyst Count
- WDFC 3
- SRRK 7
- Target Price
- WDFC $300.67
- SRRK $42.17
- AVG Volume (30 Days)
- WDFC 219.6K
- SRRK 1.3M
- Earning Date
- WDFC 07-10-2025
- SRRK 08-07-2025
- Dividend Yield
- WDFC 1.73%
- SRRK N/A
- EPS Growth
- WDFC 24.95
- SRRK N/A
- EPS
- WDFC 6.36
- SRRK N/A
- Revenue
- WDFC $612,505,000.00
- SRRK N/A
- Revenue This Year
- WDFC $8.31
- SRRK N/A
- Revenue Next Year
- WDFC $4.71
- SRRK $1,960.31
- P/E Ratio
- WDFC $34.23
- SRRK N/A
- Revenue Growth
- WDFC 6.52
- SRRK N/A
- 52 Week Low
- WDFC $208.00
- SRRK $6.76
- 52 Week High
- WDFC $292.36
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- WDFC 33.95
- SRRK 63.10
- Support Level
- WDFC $219.99
- SRRK $36.91
- Resistance Level
- WDFC $227.33
- SRRK $38.15
- Average True Range (ATR)
- WDFC 6.23
- SRRK 1.95
- MACD
- WDFC -0.78
- SRRK 0.52
- Stochastic Oscillator
- WDFC 9.10
- SRRK 68.96
About WDFC WD-40 Company
WD-40 Co manufactures and sells lubricants and cleaning products. The firm's product categories include maintenance and cleaning products. Maintenance products include the WD-40 signature brand aerosol spray lubricant as well as degreasers, rust removers, and bicycle maintenance products. Cleaning products include toilet cleaners, carpet stain removers and deodorizers, and heavy-duty hand soaps used to clean grease. The company organizes itself into three segments based on geography: Americas, Europe/Middle East/Africa, and Asia-Pacific. The majority of the company's revenue comes from the Americas segment, which includes the United States, Canada, and Latin America.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.